Isolated metastatic lung disease: review of prognostic factors for surgical treatment
##article.numberofdownloads## 12
##article.numberofviews## 164
pdf (Русский)

Keywords

pulmonary metastases
metastasectomy
isolated lung perfusion
prognostic factors
recurrent lung metastases
repeat pulmonary resection

How to Cite

Dubinina, T., Levchenko, E., Mikhnin, A., & Mamontov, O. (2021). Isolated metastatic lung disease: review of prognostic factors for surgical treatment. Voprosy Onkologii, 67(4), 449–455. https://doi.org/10.37469/0507-3758-2021-67-4-449-455

Abstract

             Currently, the surgical method remains leading in the combined treatment of pulmonary metastases. This review provides modern information about prognostic criteria for surgical treatment (primary metastasectomy and repeated resections and chemoperfusion of the lung (ILuP)) of isolated metastatic lung lesions with various primary tumors. It is concluded that knowledge of the influence of various factors on overall survival will create the basis for drawing up an accurate algorithm in determining indications for surgical treatment of patients with metastatic lung disease.

https://doi.org/10.37469/0507-3758-2021-67-4-449-455
##article.numberofdownloads## 12
##article.numberofviews## 164
pdf (Русский)

References

Каприн А.Д., Старинский В.В., Петрова В.Г. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019.

Малаев С.Г., Полоцкий Б.Е. Метастатические опухоли легких / Под ред. акад. М.И. Давыдова: Энциклопедия клинической онкологии. М., 2004:193–195.

Budczies J, von Winterfeld M, Klauschen F et al. The landscape of metastatic progression patterns across major human cancers // Oncotarget. 2015;6(1):570–83. https: // doi: 10.18632/oncotarget.2677

Ахмедов Б.П. Метастатические опухоли. М.: Медицина, 1984.

Downey RJ. Surgical treatment of pulmonary metastases // Surg Oncol Clin N Am. 1999;8(2):341–7.

Erhunmwunsee L, Tong BC. Preoperative evaluation and indications for pulmonary metastasectomy // Thorac Surg Clin. 2016;26:7–12. https: // doi: 10.1016/j.thorsurg.2015.09.002

Pfannschmidt J, Egerer G, Bischof M, Thomas M, Dienemann H. Surgical intervention for pulmonary metastases // Dtsch Arztebl Int. 2012;109(40):645–51. https: // doi: 10.3238/arztebl.2012.0645

Pastorino U, Buyse M, Friedel G et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International 171 Registry of Lung Metastases // J. Thorac. Cardiovasc. Surg. 1997;133:37–49. https: // doi: 10.1016/s0022-5223(97)70397-0

Hendriks JM, Romijn S, van Putte BP et al. Long-term results of surgical resection of lung metastases // Acta Chir Belg. 2001;101(6):267–72.

Fujimure S, Kondo Т, Yamauchi А et al. A ten — year experience with surgical resection for patients with metastatic lung tumors // Tohoku. j. exp. med. 1984;142:217–225. https: // doi: 10.1620/tjem.142.217

Ratto GB, Toma S, Civalleri D, Passerone GC, Esposito M, Zaccheo D, Canepa M, Romano P, Palumbo R, De Cian F, Scarano F, Vannozzi M, Spessa E, Fantino G. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas // J Thorac Cardiovasc Surg. 1996;112(3):614–22. https: // doi: 10.1016/S0022-5223(96)70043-0

Johnston MR, Minchen RF, Dawson CA. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma // J Thorac Cardiovasc Surg. 1995;110(2):368–73. https: // doi: 10.1016/S0022-5223(95)70232-6

Hendriks JM, Grootenboers MJ, Schramel FM, van Boven WJ, Stockman B, Seldenrijk CA, ten Broecke P, Knibbe CA, Slee P, De Bruijn E, Vlaeminck R, Heeren J, Vermorken JB, van Putte B, Romijn S, Van Marck E, Van Schil PE. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial // Ann Thorac Surg. 2004;78(6):1919–26. https: // doi: 10.1016/j.athoracsur.2004.05.058

Левченко Е.В., Тепляков В.В., Гафтон Г.И. Проблемы и перспективы регионарной перфузии // Вестник Московского онкологического общества. 2013; 594(1):5–6.

Van Schil PE, Hendriks JM, van Putte BP, Stockman BA, Lauwers PR. Isolated lung perfusion and related techniques for the treatment of pulmonary metastases // Eur J Cardiothorac Surg. 2008;33(3):487–96. https: // doi: 10.1016/j.ejcts.2007.12.009

Den Hengst WA, Van Putte BP, Hendriks JM, Stockman B, van Boven WJ, Weyler J, Schramel FM, Van Schil PE. Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases // Eur J Cardiothorac Surg. 2010;38(5):621–7. https: // doi: 10.1016/j.ejcts.2010.03.048

Beckers PAJ, Versteegh MIM, Van Brakel TJ, Braun J, Van Putte B, Maat APWM, Vergauwen W, Rodrigus I, Den Hengst W, Lardon F, De Bruijn E, Guetens G, De Boeck G, Gielis JF, Lauwers P, Denissen L, Hendriks JMH, Van Schil PE. Multicenter Phase II Clinical Trial of Isolated Lung Perfusion in Patients With Lung Metastases // Ann Thorac Surg. 2019;108(1):167–174. https: // doi: 10.1016/j.athoracsur.2019.02.071

Левченко Е.В., Сенчик К.Ю., Барчук А.С., Лемехов В.Г., Тимофеева Е.С., Дунаевский И.В., Гельфонд В.М., Горохов Л.В., Арсеньев А.И. Изолированная химиоперфузия лёгкого по поводу метастазов солидных опухолей // Онкохирургия. 2012;4:46–53.

Левченко Е.В., Калинин П.С., Сенчик К.Ю., Мамонтов О.Ю., Горохов Л.В., Барчук А.С., Мищенко А.В. Непосредственные результаты применения изолированной химиоперфузии легкого мелфаланом и цисплатином в сочетании с метастазэктомией в лечении резектабельного метастатического поражения легких // Вопросы онкологии. 2015;61(6):960–964.

Левченко Е.В., Калинин П.С., Сенчик К.Ю., Вэнь Чжан, Тин Ван, Мамонтов О.Ю., Михнин А.Е., Барчук А.С., Лемехов В.Г., Мищенко А.В., Горохов Л.В. Отдаленные результаты применения изолированной химиоперфузии легкого мелфаланом и цисплатином в сочетании с метастазэктомией в лечении резектабельного метастатического поражения легких // Вопросы онкологии. 2016;62(2):265–271.

Мамонтов О.Ю., Ван Т., Дубинина Т.В., Гумбатова Э.Д., Чжан В.Ч., Сенчик К.Ю., Левченко Е.В. Опыт проведения 180 изолированных химиоперфузий легкого с мелфаланом или цисплатином в сочетании с метастазэктомией в лечении больных метастатическим поражением лёгких. В книге: Материалы IV Петербургского международного онкологического форума «Белые ночи 2018» Тезисы. Автономная некоммерческая научно-медицинская организация «Вопросы онкологии». 2018:282.

Thomford NR, Woolner LB, Clagett OT. The surgical treatment of metastatic tumors in the lung // J. Thorac. Cardiov. Surg. 1965;49:357–363.

Hertley JE, Lopez RA, Paty P.B et al. Resection of locally recurrent colorectal cancer in the presence of distant metastases can it be justified? // Ann. surg. oncol. 2003;10:227–233. https: // doi: 10.1245/aso.2003.05.039

Elias D, Sideris L, Pocard M et al. Results of Ro resection for colorectal liver metastases associated with extrahepatic disease // Ann. surg. oncol. 2004;11:274–280. https: // doi: 10.1245/aso.2004.03.085

Salah S, Ardissone F, Gonzalez M. Pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: pooled analysis // Ann. surg. oncol. 2015;22(6):1844–1850. https: // doi: 10.1245/s10434-014-4173-9

Joosten J, Betholet J, Keemers-Gels M et al. Pulmonary resection of colorectal metastases in patients with or without a history of hepatic metastases // Eur J Surg Oncol. 2008;34:895–9. https: // doi: 10.1016/j.ejso.2008.01.009

Чиссов В.И., Трахтенберг А.Х., Пикин О.В. и др. Метастатические опухоли легких. М., 2009.

Bott MJ, Cools-Lartigue J, Tan KS, Dycoco J et al. Safety and feasibility of lung resection after immunotherapy for metastatic or unresectable tumors // Ann Thorac Surg. 2018;106(1):178–183. https: // doi: 10.1016/j.athoracsur.2018.02.030

Van der Jeught K, Xu HC, Li YJ et al. Drug resis tance and new therapies in colorectal cancer // World J Gastroenterol. 2018;24:3834–48. https: // doi: 10.3748/wjg.v24.i34.3834

Чиссов В.И., Трахтенберг А.X., Паршин В.Д., Пикин О.В. Возможности хирургического метода лечения метастатических опухолей легких // Российский онкологический журнал. 2006(4):4–10.

Bezzi М, Forte A, Nasti G et al. Surgical treatment of lung metastasis: experience with 108 cases // G. Chir. 2003;24(1):351–356.

Трахтенберг А.X., Чиссов В.И., Паршин В.Д., Пикин О.В. Хирургия двусторонних метастазов в легких // Российский онкологический журнал. 2004(1):4–7.

Левченко Е.В., Гумбатова Э.Д., Кулева С.А. и др. Изолированная химиоперфузия легкого и плевры как метод лечения у детей с распространенными формами солидных опухолей костей // Российский журнал детской гематологии и онкологии. 2019(1):40–47.

Younes RN, Gross JL, Taira AM, Martins AAC, Neves GS. Surgical resection of lung metastases: results from 529 patients // Clinics. 2009;64(6):535–41.

Treasure T et al. Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness? // Thorax. 2014;69:946–949. https: // doi: 10.1136/thoraxjnl-2013-204528

Pawełczyk K, Marciniak M, Błasiak P, Rzechonek A. Evaluation of prognostic factors in the surgical treatment of pulmonary metastases // Contemp Oncol (Pozn) 2015;19 (5):378–384. https: // doi: 10.5114/wo.2015.56007

Franco Lumachi, Giordano B Chiara, Renato Tozzoli, Alessandro Del Conte, Stefano M, Basso M. Factors Affecting Survival in Patients with Lung Metastases from Colorectal Cancer. A Short Meta-analysis // Anticancer Res. 2016;36(1):13–9.

Petrella F, Diotti C, Rimessi A, Spaggiari L. Pulmonary metastasectomy: an overview // J Thorac Dis. 2017;9(Suppl. 12):S1291–S1298. https: // doi: 10.21037/jtd.2017.03.175.

Francis Park-Yun Cheung, Naveed Zeb Alam, Gavin Michael Wright. The Past, Present and Future of pulmonary metastasectomy: a review article // Ann Thorac Cardiovasc Surg. 2019;25:129–141. https: // doi: 10.5761/atcs.ra.18-00229

Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T, Nakagawa K, Fukuhara K, Maeda H, Takeda S, Minami M, Ohno Y, Matsuda H. Thoracic Surgery Study Group of Osaka University. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma // Ann Thorac Surg. 2004;78(1):238–44. https: // doi: 10.1016/j.athoracsur.2004.02.017

Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series // Ann Thorac Surg. 2007;84(1):324–338. https: // doi: 10.1016/j.athoracsur.2007.02.093

Pfannschmidt J, Hoffmann H, Dienemann H. Thoracic metastasectomy for nonseminomatous germ cell tumors // J Thorac Oncol. 2010;5(6 Suppl 2):S182–6. https: // doi: 10.1097/JTO.0b013e3181dcf908.

Chang YY, Lin JK, Lin TC, Chen WS, Jeng KJ, Yang SH, Wang HS, Lan YT, Lin CC, Liang WY and Chang SC. Impact of KRAS mutation on outcome of patients with metastatic colorectal cancer // Hepatogastroenterology. 2014;61:1946–1953.

Pereira AA, Rego JF, Morris V, Overman MJ, Eng C, Garrett CR, Boutin AT, Ferrarotto R, Lee M, Jiang ZQ, Hoff PM, Vauthey JN, Vilar E, Maru D, Kopetz S. Association between KRAS mutation and lung metastasis in advanced colorectal cancer // Br J Cancer. 2015;112:424–428. https: // doi: 10.1038/bjc.2014.619

Renaud S, Romain B, Falcoz PE, Olland A, Santelmo N, Brigand C, Rohr S, Guenot D, Massard G. KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer // Br J Cancer. 2015;112:720–728. https: // doi: 10.1038/bjc.2014.499

Younes RN, Fares AL, Gross JL. Pulmonary metastasectomy: a multivariate analysis of 440 patients undergoing complete resection // Interact Cardiovasc Thorac Surg. 2012;14(2):156–161. https: // doi: 10.1093/icvts/ivr076

Zampino MG, Maisonneuve P, Ravenda PS et al. Lung metastases from colorectal cancer: analysis of prognostic factors in a single institution study // Ann Thorac Surg. 2014;98:1238–45.

Iizasa T, Suzuki M, Yoshida S, Motohashi S, Yasufuku K, Iyoda A, Shibuya K, Hiroshima K, Nakatani Y, Fujisawa T. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer // Ann Thorac Surg. 2006 Jul;82 (1):254–60.

Kim HK, Cho JH, Lee HY. Pulmonary metastasectomy for colorectal cancer: how many nodules, how many times? // World. j. gastroenterol. 2014;20(20):6133–6145.

Tsitsias T, Toufektzian L, Routledge T, Pilling J. Are there recognized prognostic factors for patients undergoing pulmonary metastasectomy for colorectal carcinoma? // Interact CardioVasc Thorac Surg. 2016;23:962–9. https: // doi: 10.1093/icvts/ivw273

Ахмедов Б.Б., Давыдов М.М., Федянин М.Ю., Алиев В.А., Гордеев С.С., Дадыев И.А. Факторы прогноза в хирургическом лечении метастазов колоректального рака в легких // Сибирский онкологический журнал. 2018;17(2):60–70 https: // doi: 10.21294/1814-4861-2018-17-2-60-70

Cho JH, Kim S, Namgung M et al. The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer // World J Surg Oncol. 2015;13:222.

Gonzalez M, Poncet A, Combescure C et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis // Ann Surg Oncol. 2013;20:572–9.

Rodríguez-Fuster A, Belda-Sanchis J, Aguiló R et al. Morbidity and mortality in a large series of surgical patients with pulmonary metastases of colorectal carcinoma: a prospective multicentre Spanish study (GECMP-CCR-SEPAR) // Eur J Cardiothorac Surg. 2014;45:671–6.

Suzuki H, Kiyoshima M, Kitahara M et al. Long-term outcomes after surgical resection of pulmonary metastases from colorectal cancer // Ann Thorac Surg. 2015;99:435–40.

Robinson MH, Sheppard M, Moskovic E et al. Lung metastasectomy in patients with soft tissue sarcoma // Br J Radiol. 1994;67:129–35.

Billingsley KG, Burt ME, Jara E et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival // Ann Surg. 1999;229:602–10.

Briccoli A, Rocca M, Salone M et al. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005 // Surg Oncol. 2010;19:193–9.

Kim S, Ott HC, Wright CD et al. Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes // Ann Thorac Surg. 2011;92:1780–6.

Salah S, Toubasi S. Factors predicting survival following complete surgical remission of pulmonary metastasis in osteosarcoma // Mol Clin Oncol. 2015;3:157–62.

Giuliano K, Sachs T, Montgomery E et al. Survival Following Lung Metastasectomy in Soft Tissue Sarcomas // Thorac Cardiovasc Surg. 2016;64:150–8.

Marulli G, Mammana M, Comacchio G, Rea F. Survival and prognostic factors following pulmonary metastasectomy for sarcoma // J Thorac Dis. 2017;9(Suppl. 12):S1305–S1315 https: // doi: 10.21037/jtd.2017.03.177

Li W, Zhang. Sh. Survival of patients with primary osteosarcoma and lung metastases // JBUON. 2018;23(5):1500–1504.

Dudek W, Schreiner W, Mykoliuk I, Higaze M, Sirbu H. Pulmonary metastasectomy for sarcoma — survival and prognostic analysis // J Thorac Dis. 2019;11(8):3369–3376. https: // doi: 10.21037/jtd.2019.08.10

Chudgar NP, Brennan MF, Munhoz RR, Bucciarelli PR, Tan KS, D'Angelo SP, Bains MS, Bott M, Huang J, Park BJ, Rusch VW, Adusumilli PS, Tap WD, Singer S, Jones DR. Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma // J Thorac Cardiovasc Surg. 2017;154(1):319.

Harpole DHJr, Johnson CM, Wolfe WG et al. Analysis of 945 cases of pulmonary metastatic melanoma // J Thorac Cardiovasc Surg. 1992;103:743–8;discussion 748-50.

Ollila DW, Stern SL, Morton DL. Tumor Doubling Time: A Selection Factor for Pulmonary Resection of Metastatic Melanoma // J Surg Oncol. 1998;69(4):206–11.

Schuhan C, Muley T, Dienemann H, Pfannschmidt J. Survival after pulmonary metastasectomy in patients with malignant melanoma // Thorac Cardiovasc Surg. 2011;59(3):158–62. https: // doi: 10.1055/s-0030-1250669

Neuman HB, Patel A, Hanlon C et al. Stage-IV melanoma and pulmonary metastases: factors predictive of survival // Ann Surg Oncol 2007;14:2847–53.

Essner R, Lee JH, Wanek LA et al. Contemporary surgical treatment of advanced-stage melanoma // Arch Surg. 2004;139:961–6.

Petersen RP, Hanish SI, Haney JC et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma // J Thorac Cardiovasc Surg. 2007;133:104–10.

Viehof J, Livingstone E, Loscha E, Stockhammer P, Bankfalvi A, Plönes T, Mardanzai K, Zimmer L, Sucker A, Schadendorf D, Hegedüs B, Aigner C. Prognostic Factors for Pulmonary Metastasectomy in Malignant Melanoma: Size Matters // Eur J Cardiothorac Surg. 2019;56(6):1104–1109. https: // doi: 10.1093/ejcts/ezz211

Shiono S, Kawamura M, Sato T et al. Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas // Ann Thorac Surg. 2009;88:856–60.

Young ER, Diakos E, Khalid-Raja M et al. Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta-analysis // Clin Otolaryngol. 2015;40:208–18.

Yotsukura M, Kinoshita T, Kohno M et al. Survival predictors after resection of lung metastases of head or neck cancers // Thorac Cancer. 2015;6:579–83.

Tomonari Oki, Tomoyuki Hishida, Junji Yoshida, Masaki Goto, Keigo Sekihara, Tomohiro Miyoshi, Keiju Aokage, Genichiro Ishii, Masahiro Tsuboi. Survival and Prognostic Factors After Pulmonary Metastasectomy of Head and Neck Cancer: What Are the Clinically Informative Prognostic Indicators? // Eur J Cardiothorac Surg. 2019;55(5):942–947. https: // doi: 10.1093/ejcts/ezy384

Friedel G, Pastorino U, Ginsberg RJ et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases // Eur J Cardiothorac Surg. 2002;22:335–44.

Meimarakis G, Rüttinger D, Stemmler J et al. Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer // Ann Thorac Surg. 2013;95:1170–80.

Jun Fan, Dali Chen, Heng Du, Cheng Shen, Guowei Che. Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis // J Thorac Dis. 2015;7(8):1441–1451.

Kim T, Ahn JH, You D et al. Pulmonary Metastasectomy Could Prolong Overall Survival in Select Cases of Metastatic Urinary Tract Cancer // Clin Genitourin Cancer. 2015;13:e297–304.

Alt AL, Boorjian SA, Lohse CM et al. Survival after complete surgical resection of multiple metastases from renal cell carcinoma // Cancer. 2011;117:2873–82.

Yongsheng Zhao, Jian Li, Chuan Li, Jun Fan, Lunxu Liu. Prognostic factors for overall survival after lung metastasectomy in renal cell cancer patients: A systematic review and meta-analysis // International Journal of Surgery. 2017;41:70–77.

Fan Dong, Yifan Shen1, Fengbin Gao, Tianyuan Xu, Xianjin Wang, Xiaohua Zhang, Shan Zhong, Minguang Zhang, Shanwen Chen, Zhoujun Shen. Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study // Cancer Management and Research. 2017;9:611–626.

Liu D, Abolhoda A, Burt ME et al. Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience // Ann Thorac Surg. 1998;66:1709–14.

Welter S, Jacobs J, Krbek T, Krebs B, Stamatis G. Long-term survival after repeated resection of pulmonary metastases from colorectal cancer // Ann Thorac Surg. 2007;84 (1):203–210.

Masatsugu Hamaji, Fengshi Chen, Ei Miyamoto, Takeshi Kondo, Keiji Ohata, Hideki Motoyama, Kyoko Hijiya, Toshi Menju, Akihiro Aoyama, Toshihiko Sato, Makoto Sonobe, Hiroshi Date. Surgical and Non-Surgical Management of Repeat Pulmonary Metastasis From Sarcoma Following First Pulmonary Metastasectomy // Surg Today. 2016;46(11):1296–300. https: // doi: 10.1007/s00595-016-1312-x

Yano T, Fukuyama Y, Yokoyama H, Tanaka Y, Miyagi J, Kuninaka S, Asoh H, Ichinose Y. Failure in resection of multiple pulmonary metastases from colorectal cancer // J Am Coll Surg. 1997 Aug;185 (2):120–2.

Тимофеева Е.С., Левченко Е.В., Моисеенко В.М. Изолированная перфузия легкого цитостатиками // Вопросы онкологии. 2011;57(2):147–154.

Hengst WA, Hendriks JM, Balduyck B et al. Phase II Multicenter Clinical Trial of Pulmonary Metastasectomy and Isolated Lung Perfusion with Melphalan in Patients with Resectable Lung Metastases // J. thorac. oncol. 2014;9(10):1547–1553.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2021